Welcome to our dedicated page for XWELL news (Ticker: XWEL), a resource for investors and traders seeking the latest updates and insights on XWELL stock.
XWELL, Inc. (Nasdaq: XWEL) is a premier global wellness holding company dedicated to delivering health and wellness services to travelers. The company's flagship brand, XpresSpa, boasts the title of the largest airport spa company globally, with 57 locations across 23 airports. XpresSpa offers a range of premium spa services tailored to the needs of busy travelers, including massages, nail services, skincare treatments, and exclusive travel products.
Alongside XpresSpa, XWELL operates the Treat brand, which focuses on travel health and wellness by offering spa services at airports. The company also runs XpresTest, a segment providing COVID-19 screening and diagnostic testing in collaboration with the CDC. Additionally, XWELL’s portfolio includes Naples Wax Center, known for its high-performing locations offering face and body waxing services, and HyperPointe, which provides specialized marketing services.
In recent developments, XWELL has introduced automated beauty and wellness experiences, such as the Clockwork MiNiCURE, which delivers express manicures through advanced robotic technology. This innovation is part of XWELL’s commitment to enhancing customer experiences and operational efficiency. The company has also expanded its wellness services with automated massage chairs and IV hydration drip therapy, aiming to boost revenue and provide high-margin services.
Financially, XWELL had cash and cash equivalents of $8.4 million and marketable securities worth $14.6 million as of December 31, 2023. Despite a challenging year with total revenue of $30.1 million and notable non-cash goodwill impairment charges, the company remains focused on operational efficiency and revenue growth through new service offerings and strategic partnerships.
Strategically, XWELL continues to enhance its service offerings and expand its global footprint, including recent openings in Abu Dhabi and planned expansions in key locations such as New York City's Penn Station. The company’s commitment to public health is evident through its TGS program, aimed at expanding biosecurity infrastructure with support from the CDC.
XWELL, Inc. (Nasdaq: XWEL) announced its financial results for the year ending December 31, 2022, reporting total revenue of $55.9 million, a decrease from $73.7 million in 2021. The net loss attributable to common shareholders was $32.8 million, compared to a net income of $3.3 million the previous year. Key initiatives include the opening of new XpresSpa locations and partnerships to integrate innovative health technologies. The company’s operational adjustments led to a reduction in cash operating costs and the closure of underperforming locations. Financial metrics indicate a working capital of $36.4 million with no long-term debt. XWELL continues to focus on growth in wellness services at airports, expanding its biosurveillance program, and enhancing retail strategies.
XWELL, Inc. (Nasdaq: XWEL) will announce its fiscal year 2022 financial results on April 17, 2023, after market close, followed by a webcast and conference call at 5:00 PM ET. Interested investors are encouraged to listen via the webcast due to limited phone line capacity.
The Company operates four brands: XpresSpa, a leader in airport wellness services with 35 locations; Treat, a travel health brand; XpresCheck, providing COVID-19 testing; and HyperPointe, a digital healthcare analytics firm. XWELL emphasizes the importance of health and wellness solutions for travelers.
Forward-looking statements are included regarding future performance expectations, which are not guaranteed and involve risks.